O'Riordan J, Finch A, Lawlor E, McCann S R
Department of Haematology, St James's Hospital, Dublin, Ireland.
Bone Marrow Transplant. 1992 Jan;9(1):27-30.
This study was undertaken to ascertain the frequency of compatible sibling donors for individuals requiring bone marrow transplantation (BMT) in Ireland. During the study period 1984-89, a total of 392 patients were HLA typed. Of these, 218 (55.6%) had a compatible sibling donor. Among the latter there were 4 degrees of compatibility: 168 (42.9%) were HLA-A,B,DR identical MLC unreactive: three (0.8%) were HLA-A,B,DR identical MLC reactive: 12 (3.0%) were HLA-A,B,DR identical (no MLC performed) and 35 (8.9%) were HLA-A, B identical (no DR or MLC performed). The leukaemias and aplastic anaemia comprised 82.9% of all requests. The majority of patients with acute myeloid leukaemia (64.4%), acute lymphoblastic leukaemia (51.2%), chronic myeloid leukaemia (73.9%) and aplastic anaemia (77.3%) had a potential sibling donor. Subsequently 144 of these patients had an allogeneic BMT, 79.9% of which were for patients with leukaemia (acute and chronic). This study found that there was a higher probability of finding a donor within the family than reported in most series. A clear relationship was demonstrated between family size and the likelihood of obtaining a HLA-identical sibling donor.
本研究旨在确定爱尔兰需要进行骨髓移植(BMT)的个体中,同胞供者配型相合的频率。在1984年至1989年的研究期间,共对392例患者进行了HLA分型。其中,218例(55.6%)有配型相合的同胞供者。在这些配型相合的供者中,有4种相合程度:168例(42.9%)HLA - A、B、DR完全相同且混合淋巴细胞培养无反应;3例(0.8%)HLA - A、B、DR完全相同但混合淋巴细胞培养有反应;12例(3.0%)HLA - A、B、DR完全相同(未进行混合淋巴细胞培养);35例(8.9%)HLA - A、B相同(未检测DR及未进行混合淋巴细胞培养)。白血病和再生障碍性贫血占所有申请的82.9%。大多数急性髓系白血病患者(64.4%)、急性淋巴细胞白血病患者(51.2%)、慢性髓系白血病患者(73.9%)和再生障碍性贫血患者(77.3%)有潜在的同胞供者。随后,这些患者中有144例进行了异基因骨髓移植,其中79.9%是针对白血病患者(急性和慢性)。本研究发现,在家族中找到供者的概率高于大多数系列报道。家庭规模与获得HLA相同的同胞供者的可能性之间存在明显的关系。